In stock
ELIGARD 22.5 MG POWDER FOR SOLUTION FOR INJECTION 22.5 mg Powder and solvent for solution for injection Vial
In stock
Only 1 left
SKU
10331014310
Eligard 22.5 mg is a long-acting prescription medication for advanced prostate cancer. It contains leuprolide acetate, a GnRH agonist that helps reduce testosterone levels to slow cancer growth. Administered as a subcutaneous injection every three months by a healthcare professional.
Product Description
Eligard 22.5 mg is a prescription medication containing leuprolide acetate, indicated for the palliative treatment of advanced prostate cancer. It is designed to provide continuous suppression of testosterone production.Benefits of Use
Eligard 22.5 mg offers significant benefits in managing advanced prostate cancer: It acts as a long-acting gonadotropin-releasing hormone (GnRH) agonist. It effectively reduces serum testosterone levels to castration levels, which can slow the growth of hormone-sensitive prostate cancer. Provides a convenient subcutaneous injection administered typically every three months, reducing the frequency of administration. This sustained action helps in maintaining a consistent therapeutic effect.How to Use
1. Eligard 22.5 mg is intended for subcutaneous injection only. 2. It must be prepared and administered by a qualified healthcare professional. 3. The standard dose is administered once every three months. 4. Always follow your doctor's specific instructions regarding the administration schedule and any concomitant therapies. 5. Do not attempt to self-administer this medication.Caution & Warnings
- Do not use Eligard 22.5 mg if you have a known allergy to leuprolide, GnRH, GnRH agonists, or any other components of the formulation.
- An initial temporary increase in testosterone levels (tumor flare) may occur upon treatment initiation, which can transiently worsen symptoms; appropriate clinical management may be necessary.
- Long-term use of Eligard 22.5 mg may lead to decreased bone mineral density and an increased risk of osteoporosis.
- Report any new or worsening symptoms immediately, especially those related to urinary obstruction or spinal cord compression.
- This medication may impact blood sugar control; regular monitoring of glucose levels is advisable, especially for diabetic patients.
- There is a potential for an increased risk of cardiovascular events; discuss your personal risk factors with your healthcare provider.
- Regular monitoring of prostate-specific antigen (PSA) and testosterone levels is recommended to assess treatment response.
- Eligard 22.5 mg is not indicated for use in women or children.
- Inform your doctor about all other medications, supplements, and herbal remedies you are currently taking to avoid potential drug interactions.
Ingredients
Active Ingredient: Leuprolide acetate. Other components include a powder for solution for injection and a sterile solvent for reconstitution.Product Details
Brand: Eligard Manufacturer: Astellas Pharma Drug Type: Prescription Only Medicine Form: Powder and solvent for solution for injection Strength: 22.5 mg Administration Route: Subcutaneous Storage: Store in a refrigerator (2-8°C). Do not freeze. Package: Single-dose vial kit designed for reconstitution and administration.| Gtin | 2504245206 |
|---|---|
| Recommended Sale Price | 796.8 |
| Is Wasfaty Product | No |
| Brand | Not Defined |
| Ingredient Name | LEUPRORELIN |
| SFDA Reg. No | 2504245206 |
| IBC | 2504245206 |
| Drug Type | Prescription |
| Scientific Name | Leuprolide acetate |
| Strength | 22.5 |
| Strength Unit | mg |
| Form | Powder and solvent for solution for injection |
| Admin Route | Subcutaneous |
| Size | 1 |
| Size Unit | Vial |
| Package Types | Single-dose vial kit |
| Package Size | 1 vial |
| shelfLife | 36 months |
| Storage conditions | Store in a refrigerator (2-8°C). Do not freeze. |
| Refrigerator Storage | Yes |
| Distribute area | Saudi Arabia |
Products you might like
